|
|
Product Description
The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices.Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens.
New in the 26th edition:
- First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactam
- Replacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)
- Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infections
- Updates on management of influenza, including baloxavir (now approved for children >12 years)
- New approaches to treatment of mucomycosis
- New recommendations for malaria
- More than 150 new references!
Customers Who Bought This Item Also Bought
- The Harriet Lane Handbook: The Johns Hopkins Hospital (Mobile Medicine)
- Fleisher & Ludwig's Textbook of Pediatric Emergency Medicine
- The Harriet Lane Handbook: Mobile Medicine Series
- Pediatric & Neonatal Dosage Handbook
- Bright Futures: Guidelines Pocket Guide
- Berkowitz's Pediatrics: A Primary Care Approach
- Nelson Pediatric Symptom-Based Diagnosis
- Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents
- Pediatric Primary Care
- Red Book 2018: Report of the Committee on Infectious Diseases
*If this is not the "2020 Nelson's Pediatric Antimicrobial Therapy" product you were looking for, you can check the other results by clicking this link
.
Details were last updated on Nov 8, 2024 05:54 +08.
